US
(888) 440-0954

About Us

MedGenome is a genomics and clinical data driven diagnostics and drug discovery research company founded in 2013.

MedGenome is the market leader in genetic diagnostics in India and one of the highest throughput NGS sequencing lab in South Asia. We possess state-of-the-art Next Generation Sequencing (NGS) facility housing cutting-edge genome sequencing platforms such as Illumina’s NovaSeq, HiSeq X , HiSeq 4000 and 2500, MiSeq, etc.

Our Sequencing facility is supported by a sophisticated IHC pathology lab and we even utilize modern molecular techniques such as FISH, PCR, Sanger Sequencing and Microarray to offer comprehensive diagnostic solutions to researchers, doctors and hospitals. We currently offer more than 475 genetic tests across several disease categories such as paediatrics, neurology, oncology, hematology, endocrinology, nephrology, ophthalmology, etc.

Our footprint covers the whole of India and parts of South Asia with over 550 hospitals and more than 5,500 clinicians leveraging our services. MedGenome has successfully partnered with major hospitals and research centres across India. We have setup Genome Centres in key cities across India to create awareness about the utility and efficacy of genetic testing in a clinic and offer services that are relevant and affordable to patients to manage their health outcomes.

Innovation is a core belief and many of our tests have been developed in-house including our comprehensive Gene Panels. Our liquid biopsy test OncoTrack for monitoring cancer treatment is the only NGS-based ctDNA test available in India. We even offer carrier screening test for couples planning a baby and whole exome sequencing test for identifying gene mutations in rare diseases. We believe in continuous innovation to help reduce the cost of genetic tests and empower clinicians with actionable clinical insights to provide better outcomes.

As a firm believer in quality, MedGenome adheres to the highest international standards when it comes to our services and have obtained the prestigious CAP accreditation for all our Labs across India. Our business has grown two-fold in the past 3 years and now we also offer diagnostics services in South Asia, Middle East, Eastern Europe and Africa.

Our expert scientific team, data scientists and bioinformaticians fuel our genomics research and we have successfully built research pipelines addressing immuno-oncology, biomarker discovery, companion diagnostics and population-based genomic studies that taps the rich Indian diverse genotype.

We have worked extensively on building clinical databases of more than 1 million patients through collaborations. We have a repository of clinical, phenotypic and genomics data for 170,000 patients to provide insights into complex diseases at genetic and molecular level. Since the company works extensively in the Indian sub-continent, we have access to data that provides insights into genetic diversity of Indian population for more than 4,500 population groups.

Over the years we have also focussed on building tools and IP that could be leveraged by researchers and pharmaceutical companies to aid in drug discovery and clinical trial. These tools cover disease segments such as oncology, diabetes, ophthalmology, cardiology and other rare diseases.

MedGenome is a founding member of GenomeAsia 100K, an initiative to sequence 100,000 Genomes in Asia, which would enable us to provide a unique resource of genetic research for the world.

Headquartered in California, USA we have a workforce of more than 450 people across the globe with offices in Bangalore, Kochi, Mumbai, Delhi, Chennai, and Singapore.

Sam Santhosh

Founder Chairman and Global CEO

Sam Santhosh founded MedGenome in 2013 as a spin off from SciGenom, which he had founded in 2009. He is a science savvy entrepreneur with close to three decades of experience in launching and running successful businesses. Passionate about science & technology, Sam firmly believes that as technology was the key driver for growth in the latter half of the 20th century, so would be genomics in the 21st century. Through MedGenome, he has transformed the medical genomics and diagnostics space in India and showed path for others to emulate. At MedGenome, he provides strategic direction, oversees business development plans and helps raise capital for future growth. He is also an investor and mentor for many other companies. Currently, he is an Advisor/Board member at Impelsys Inc, New York, ePay Healthcare, San Francisco, SciGenom Labs, Cochin, AgriGenome, Hyderabad, Emerge Ventures, Singapore and the Centre for Commercialization of Antibodies (CCAB) Toronto, Canada. Previously, he was the Founder, CEO and Managing Director of California Software Limited (Calsoft). Sam holds a degree in Engineering from University of Calicut and an MBA from IIM Calcutta. He has attended Executive education programs at MIT and Singularity University.

X

Sam Santosh

Founder Chairman and Global CEO

DR. AMITABHA CHAUDHURI

Vice President, R & D

Dr. Amitabha Chaudhuri brings over two decades of experience in discovering and validating novel targets and biomarkers of diseases, most extensively in oncology. His earlier work at CuraGen Corporation and Genentech has equipped him to work with multidimensional data from high throughput protein-interaction and NGS technologies for drug discovery work. Amit Chaudhuri is the Head of R&D at MedGenome and is particularly responsible for driving the novel Immuno-oncology products and solutions. Through his leadership, MedGenome has built its unique solutions to address challenges facing the IO field. He is actively involved in IO research in India in diseases such as Head & Neck cancer and familial colorectal cancer with a goal to target these diseases using cancer vaccines and combination therapy. He is also driving new research in the areas of autoimmunity and liver diseases at MedGenome. He holds a Ph.D. in Biochemistry from the Indian Institute of Science, Bangalore and did his Post-Doctoral research training at Massachusetts General Hospital, Harvard Medical School and at the Department of Molecular & Cellular Biology, Harvard University.

X

DR. ERIC STAWISKI

Vice President, Bioinformatics

Dr. Eric Stawiski is responsible for commercial, research and development of bioinformatics operations at MedGenome. Previously, he was with Genentech for 8 years as a Senior Scientist and Bioinformatics Group Leader. His team focused on analyzing RNA-seq, exome and copy-number data to identify potential driver genes and drug targets in cancers as well as evaluating emerging sequencing technologies. His work has led to multiple first author papers in Nature, Nature Genetics and other high impact journals. He holds a PhD in Molecular Cellular and Developmental Biology from the University of California, Santa Cruz and a B.S. in Biochemistry and Cell Biology from University of California, San Diego.

X

Dr. Timothy J. Triche

Laboratory Director

Dr. Timothy J. Triche, MD, PhD, trained as an anatomic pathologist at Wash U. Medical Center, then spent 15 years at the National Cancer Institute as a staff pathologist and researcher studying cancer biology, with an emphasis on pediatric cancer. He subsequently moved to USC/CHLA as Chair, Dep’t of Pathology and Laboratory Medicine, where he established a grant funded research program in cancer genomics. More recently he founded the Center for Personalized Medicine at CHLA and has developed a series of next-gen based cancer diagnostics and prognostics. His current research is focused on the role of long non-coding RNA in cancer progression and development of a targeted nanoparticle therapeutic platform useful in delivering a wide range of therapeutics, including small molecule agents, nucleic acid, and gene editing constructs, among others. He also serves as Laboratory Director for MedGenome NGS lab in Foster City, California.

X

HIRANJITH G H

Director, Corporate Planning, Marketing & Communications

Hiranjith has over 15 years of experience in defining and executing commercial strategies within multi-national organizations. In his prior experience, he has led engagements with Janssen Biotech (formerly Centocor biotech), GE and Medimmune, among others, with the niche pharma consulting firm, ZS Associates. He has extensive experience with strategic planning for launch brands and in-market brands as part of franchise planning teams at Novartis. He is currently responsible for driving sales, marketing and partnership activities for MedGenome in the US. He transitioned to focus on the US business after a successful stint as the Director for Corporate Planning, Marketing and Communications with MedGenome in India. His healthcare experience in brand planning, primary & secondary market research, analytics, forecasting and competitive intelligence is leveraged in designing the commercial campaigns for the markets that MedGenome focuses on. Hiranjith holds a Master’s in Business Administration and an engineering degree.

X

DR. VL RAMPRASAD

Chief Operating Officer

Dr. Vedam Ramprasad is a scientist with several peer-reviewed publications to his credit. He believes in harnessing the power of genomics for providing better outlook to patients. He has been with MedGenome since its inception and spearheads operations and strategy. He has been a prime driver in building the diverse genetic testing portfolio MedGenome offers. He is also credited for launching some of the critical genetic tests at affordable price which include the Non-Invasive Pre-natal test (NIPT), Carrier screening test, and Liquid Biopsy to name a few. His commitment to adhere to the highest quality standards and processes has been instrumental in obtaining CAP accreditation for MedGenome. With over a two decade of experience, Dr. Ramprasad was previously associated with Vision Research Foundation, Sankara Nethralaya, Spinco Biotech and SciGenom labs. He holds a Master’s degree and a PhD from BITS, Pilani.

X

DR. ROHIT GUPTA

Chief Information Officer

Dr. Rohit Gupta is a genomic data expert who comes with over 15 years of experience in developing and applying data-driven methods in diverse application areas such as civil infrastructure, earth sciences, e-commerce, medicine, computational biology and clinical genomics. He is also an adjunct professor at IIT-Madras and IIIT-Delhi, where he actively participates in teaching and research activities to bridge the gap between academia and industry. At MedGenome, he heads the Bioinformatics, Software and IT department, both for commercial and research vertical. His role is critical in ensuring secure handling and processing of large volume of genetic data generated through research and diagnostics. Prior to joining MedGenome, he was the Director of Bioinformatics at Strand Life Sciences, India and had worked with Genentech and Mayo Clinic, USA where he won several awards for his work. Rohit holds a B.Tech degree from IIT Roorkee and M.S & PhD (CS) degrees from the University of Minnesota, USA. He has several peer-reviewed publications to his credit in reputed journals and international conferences.

X

SURAJIT CHAKRABARTTY

Chief Financial Officer

Surajit Chakrabartty is a financial expert with over 18 years of experience across diverse sectors such as e-Commerce, Retail, Media & Advertising and Manufacturing. Process implementation and building financial enterprises are his core strengths. In his career span, Surajit has successfully managed multiple projects including ERP implementations and internal control systems design across organisations. At MedGenome, he leads the finance function and is responsible for treasury management, financial forecasting, planning, and budgeting, reporting and assessing future business risks. He has successfully automated multiple processes while adhering to quality standards, rules and regulations. Surajit brings with him extensive experience and in-depth expertise of debt and other financing developed over his stellar career. Previously, he was associated with Redbus.in, Medybiz Pharma Private Limited and Rediffusion Y&R. He is also featured as one amongst India’s Most Influential CFOs (awarded by the Chartered Institute of Management Accountants). Surajit is a Chartered Accountant from ICAI.

X

SANJAY KUMAR SHARMA

Chief Commercial Officer

Sanjay Kumar Sharma is a sales and marketing professional with more than two decades of experience spanning sales, marketing, operations and P&L management. At MedGenome, he is responsible for commercial strategy, market development and expansion. Under his leadership, MedGenome has been able to expand its network of clinicians and hospitals. Prior to MedGenome, he was associated with Oncquest Labs, Guardian Lifecare, Ranbaxy and Dabur Ayurved. Sanjay holds a Post Graduate Diploma in Business Management from Birla Institute of Management Technology and a Bachelor’s Degree from University of Delhi.

X

US

Dr. Amitabha Chaudhuri
Dr. Amitabha Chaudhuri
Vice President, R & D
Eric Stawiski
Dr. Eric Stawiski
Vice President, Bioinformatics
Hiranjith G H
Hiranjith G H
Director, Corporate Planning, Marketing & Communications

INDIA

Dr. V L Ramprasad
Dr. V L Ramprasad
Chief Operating Officer
Dr. Rohit Gupta
Dr. Rohit Gupta
Chief Information Officer
Surajit Chakrabartty
Surajit Chakrabartty
Chief Financial Officer
Sanjay Kumar Sharma
Sanjay Kumar Sharma
Chief Commercial Officer

SAM SANTHOSH

Sam Santhosh founded MedGenome in 2013 as a spin off from SciGenom, which he had founded in 2009. He is a science savvy entrepreneur with close to three decades of experience in launching and running successful businesses. Passionate about science & technology, Sam firmly believes that as technology was the key driver for growth in the latter half of the 20th century, so would be genomics in the 21st century. Through MedGenome, he has transformed the medical genomics and diagnostics space in India and showed path for others to emulate. At MedGenome, he provides strategic direction, oversees business development plans and helps raise capital for future growth. He is also an investor and mentor for many other companies. Currently, he is an Advisor/Board member at Impelsys Inc, New York, ePay Healthcare, San Francisco, SciGenom Labs, Cochin, AgriGenome, Hyderabad, Emerge Ventures, Singapore and the Centre for Commercialization of Antibodies (CCAB) Toronto, Canada. Previously, he was the Founder, CEO and Managing Director of California Software Limited (Calsoft). Sam holds a degree in Engineering from University of Calicut and an MBA from IIM Calcutta. He has attended Executive education programs at MIT and Singularity University.

MAHESH PRATAPNENI

Mahesh Pratapneni is the cofounding investor and Board Member of MedGenome. He has led strategy, partnerships and corporate development including fundraising for the company. Mahesh is Founder and MD of Emerge Ventures that specializes in incubating product companies in the education, healthcare, and data/analytics sectors. He is known for building outstanding global teams and comes with broad experience in product visualization, development, management and building global delivery models. He holds a B. Tech. degree in Electronics and Communications from IIT Madras and an MBA from IIM Calcutta.

DHIRAJ C RAJARAM

Dhiraj Rajaram is an entrepreneur who is passionate about technology. In his career spanning over two decades he has been named as Fortune’s 40 under 40 and awarded Entrepreneur of the Year by Ernst & Young and Economic Times. He is the founder, Chairman and CEO of Mu Sigma Inc, which has got the distinction of being one of the first Indian technology companies that is valued over 1 billion USD. At Mu Sigma, Dhiraj is responsible for vision and strategic direction, building teams, aligning organizational resources to a customer centric vision and delivering profitable growth. Prior to Mu Sigma, Dhiraj worked as a management consultant at Booz Allen Hamilton and PricewaterhouseCoopers. He holds an MBA from the University of Chicago, an M.S. in Computer Engineering from Wayne State University, and a bachelor’s degree from College of Engineering Guindy, Anna University.

ANJANA SASIDHARAN

Anjana Sasidharan is a Principal with Sequoia Capital India. She focuses on investments in the consumer and healthcare sectors. Prior to joining Sequoia, Anjana was associated with McKinsey & Co for four years where she advised clients across multiple sectors in India on Strategy as well as Sales & Marketing. She holds an MBA from the IIM, Ahmedabad and a BS in Electronics & Communication Engineering from NIT, Tiruchirappalli where she was a Lucent Global Science Scholar.

Dr. Stephan C Schuster

Dr. Stephan C Schuster is currently the Research Director and Professor at the Singapore Centre on Environmental Life Sciences Engineering, Nanyang Technical University, Singapore. Dr .Schuster has over 15 years of experience setting up and operating centralized sequencing core labs at Max Plank Institute in Germany and Penn State in the US. He won the Science magazine’s break through of the year award in 2006 (runner up) and 2008 (Top 10). He was also awarded the Time Magazine’s top ten Scientific discoveries in 2008 and along with W. Miller was among Time magazine’s top 100 most influential people of 2009. His research interests include Metagenomics, Evolutionary Biology and ancient DNA.

Dr. Ishwar C. Verma

Dr. I. C. Verma is currently the head of the Department of Genetic Medicine at Sri Ganga Ram Hospital, New Delhi. Previously he was a Professor of Pediatrics and Genetics in AIIMS, New Delhi. He received genetics training in the UK, USA & Switzerland. He is a Fellow of the Royal College of Physicians, London, the American Academy of Pediatrics, and the National Academy of Medical Sciences, New Delhi. He has received a number of national awards – Ranbaxy Science Award, ICMR, NAMS and BC Roy Medical Council award. He is a Member and Vice-chairman of the Ethics Committee of the International Human Genome Organization (HUGO) and serves as a genetics adviser for the WHO in Geneva, and to Roche Genetics in Basel. He has vast experience in genetic counseling, serving about 2000 cases with genetic problems every year, and bringing the benefits of genetics and genomics to large number of patients.

Dr. C. N. Ramchand

Dr. C. N. Ramchand serves as the Chief Executive Officer and President of Saksin Lifesciences Pvt Ltd. and MagGenome Technologies Pvt Ltd. Dr.Ramchand has 30 years of industrial and academic experience in the field of drug discovery, nanotechnology and nutraceuticals. He has held key leadership positions such as India Director at Kemin Industries, India and Vice President & Head of New Drug Discovery (biological) Research Programme at Sun Pharma Advances Research Centre (SPARC) India. He has also held the position of Joint Co-ordinator and Head, Laboratory Research Program at Biomedical Sciences, University of Sheffield and Northern General Hospital Sheffield, UK, a prestigious University Position. Prior to this he was the Sr. Scientist and Project Head at the Institute of Biological Psychiatry at University of Wales, Bangor, UK. Dr. Ramchand has published over 70 peer-reviewed papers in international journals, edited 5 books, has over 40 patents.

MEDGENOME VISION IS SUPPORTED BY

MedGenome Institutional Ethics Committee (MG-IEC)

Introduction

MedGenome Institutional Ethics Committee (MG-IEC) is an independent body constituted under the authority of the chairman with the primary goal of safeguarding the rights and wellbeing of research participants. The chairperson of MG-IEC is appointed from a different institution and the appointment of IEC members is solely based on their competence, experience and integrity.

Responsibilities of MG-IEC

The MG-IEC will review all types of research proposals involving human participants with a view to safeguard the dignity, rights, safety and wellbeing of all actual and potential research participants before approving the research proposals. The goals of research, however important, should never be permitted to override the health and wellbeing of the research subjects.

The MG-IEC will ascertain whether all the cardinal principles of research ethics viz., Autonomy, Beneficence, Non-maleficence, Respect for Free and Informed Consent, Respect for Human Dignity, Respect for Vulnerable Persons, Respect for Privacy and Confidentiality and Justice are taken care of in planning, conducting and reporting of the proposed research. For this purpose, it will look into the aspects of protocol review, selection of participants, voluntary participation of potential participants, informed consent process, risk benefit ratio, distribution of burden and benefit, maintenance of privacy and confidentiality and provisions for appropriate compensations. It will review the proposals before the commencement of the study as well as review periodically until the completion of the study through appropriate well-documented procedures.

MEMBERS OF MG-IEC
Chairperson Dr. Vijayalakshmi M
Member Secretary Padmavathy R
Clinician Dr. Durgapoorna
Scientist Dr. Lakshmi Mahadevan
Basic Medical Scientist Dr. Kumaramanickavel G
Scientist Dr Ramchand CN
Legal Expert/Lawyer Srijith PR
Philosopher Dr. Rajamohan EK
Basic Medical Scientist Dr. Álex Baby Paul
Lay Person Babu AG
Social Scientist / Social Worker Vinita Vijayakumar

Phone Number : 9496665432 / 9940678632

*
 
*
*